Morphine Sulfate Wockhardt Uk (Morphine Sulfate)

Morphine Sulfate acts as a full agonist at mu‑opioid receptors in the central nervous system. By binding these receptors, it inhibits the transmission of nociceptive signals, alters pain perception, and produces sedation and respiratory effects.

The prescribed dose of Morphine Sulfate is individualized by the treating clinician based on factors such as pain severity, patient weight, renal and hepatic function, route of administration, and prior opioid exposure. No standardized public dosing regimen is provided.

Morphine is classified as pregnancy category C, meaning it should be used only if the potential benefit justifies the potential risk to the fetus. It is excreted in breast milk, so caution is advised for nursing mothers and alternative therapies should be considered when possible.

Submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and the necessary import documentation.

Compared with weaker opioids such as codeine, morphine offers higher potency suitable for moderate to severe pain. Compared with synthetic opioids like fentanyl, morphine has a longer duration of action but may be associated with a higher incidence of constipation and other gastrointestinal side effects.

Store at controlled room temperature, below 25 °C, in the original packaging, protected from light and moisture. Do not freeze the product and keep it out of reach of unauthorized personnel.

Morphine Sulfate is supplied as a sterile solution for injection and may be given intramuscularly, intravenously, or subcutaneously by a qualified healthcare professional using aseptic technique and appropriate dosing calculations.

The most critical risks include respiratory depression, profound sedation, hypotension, and the potential for dependence, abuse, or overdose. Immediate medical attention is required if the patient shows signs of shallow breathing, loss of consciousness, or severe hypotension.

Patients with known hypersensitivity to morphine or other opioids, severe respiratory insufficiency, acute or severe asthma, paralytic ileus, or significant head injury should avoid morphine. Caution is also advised for individuals with uncontrolled hypertension or a history of substance misuse.